GYRE·403783103·US·equity·Healthcare - Biotechnology
GYRE (Gyre Therapeutics, Inc.) is held by 34 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($8.5M), BlackRock, Inc. ($5.1M), GEODE CAPITAL MANAGEMENT, LLC ($3M). Net institutional sentiment: Bullish.
See how GYRE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer